TGen study uncovers possible genetic markers in breast cancer that spreads to the brain

New treatments might be possible for patients who now have little hope

2014-02-11

(Press-News.org) PHOENIX, Ariz. — Feb. 10, 2014 — The Translational Genomics Research Institute (TGen) has uncovered possible genetic origins of breast cancer that spreads to the brain, according to a first-of-its-kind study published in the scientific journal PLOS ONE.

The compendium of genetic targets uncovered by TGen now can be used to identify potential new methods of diagnosis and new drug therapies for the estimated 45,000 patients in the U.S. each year whose cancer spreads from the breast to the brain.

The 3-year study is significant since these patients currently have few treatments options — surgery and radiation — and they usually are ineligible for clinical drug trials. Their prognosis is poor, with fewer than 2 percent surviving more than two years

"This is really a significant problem and a huge unmet need. We now want to dig deeper and uncover more specific genomic links and study new ways to treat these patients so we can improve outcomes," said Dr. Bodour Salhia, an Assistant Professor in TGen's Integrated Cancer Genomics Division and the study's lead and co-senior author.

"In this study, we see that breast-brain metastasis retain many features found in primary breast cancer, but we still need to better understand the differences," said Dr. Salhia. "Knowing the key drivers of brain metastasis may lead to preventive measures, as well."

After lung cancer, breast cancer is the second most common cancer that spreads to the brain. Chemotherapy generally has not been used to treat brain cancer, because of the blood-brain barrier that exists between the bloodstream and the cerebrospinal fluid surrounding the brain. However, some small molecule drugs can cross this barrier and form the basis of targeted therapies.

The overall goal of the TGen study was to look at genomic and epigenomic events to understand the causes of breast cancer brain metastatic lesions, and identify potential new therapeutic targets.

The TGen team performed deep genomic profiling, integrating gene copy number, gene expression and DNA methylation datasets on a collection of 35 breast-brain metastases samples. The study, Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis, published Jan. 29, is the first of its kind to incorporate all of those avenues of inquiry in the study of this disease.

Some of the common genetic alterations identified in the study were gains and losses in chromosome 8, as well as cell proliferation and cell-cycle progression — key mechanisms of cancer caused by genetic alterations — linked to the genes AURKA, AURKB and FOXM1.

"This groundbreaking study sets the stage for more exacting research, using the latest genomic technologies and aimed at developing new therapies that could help the tens of thousand of patients who urgently need our help," said Dr. Nhan Tran, an Associate Professor of TGen's Cancer and Cell Biology Division and the study's other co-senior author.

INFORMATION:

This work was supported in part by the National Institutes of Health (NIH), the Flinn Foundation, and C.A.R.E. (Cancer Awareness Through Research & Education).

About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: http://www.tgen.org.

Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org

ELSE PRESS RELEASES FROM THIS DATE:

New advance in 3-D printing and tissue engineering technology

2014-02-11

Boston, MA – Researchers at Brigham and Women's Hospital (BWH) and Carnegie Mellon University have introduced a unique micro-robotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3D printing. Described in the Jan. 28, 2014, issue of Nature Communications, the research was conducted by Savas Tasoglu, PhD, MS, research fellow in the BWH Division of Renal Medicine, and Utkan Demirci, PhD, MS, associate professor of Medicine in the Division of Biomedical Engineering, part of the BWH Department of Medicine, in collaboration ...

Breast cancer drug fights fungal disease

2014-02-11

Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more HIV/AIDS patients than tuberculosis, appear in mBio®, the online open-access journal of the American Society for Microbiology (ASM.) "This work sets the stage for additional animal studies to see if tamoxifen can be used as a drug in people and will allow us to design new drugs related to tamoxifen that are better antifungals," says Damian Krysan ...

Study shows drop in crime rates is less where Wal-Mart builds

2014-02-10

Communities across the United States experienced an unprecedented decline in crime in the 1990s. But for counties where Wal-Mart built stores, the decline wasn't nearly as dramatic. "The crime decline was stunted in counties where Wal-Mart expanded in the 1990s," says Scott Wolfe, assistant professor of criminology and criminal justice at the University of South Carolina and lead author of a new study. "If the corporation built a new store, there were 17 additional property crimes and 2 additional violent crimes for every 10,000 persons in a county." The study, titled ...

Newly found tactics in offense-defense struggle with hepatitis C virus

2014-02-10

The hepatitis C virus (HCV) has a previously unrecognized tactic to outwit antiviral responses and sustain a long-term infection. It also turns out that some people are genetically equipped with a strong countermeasure to the virus' attempt to weaken the attack on it. The details of these findings suggest potential targets for treating HCV, according to a research team led by Dr. Ram Savan, assistant professor of immunology at the University of Washington. The study was published in Nature Immunology. HCV infects more than 150 million of the world's people. The ...

NTU showcases expertise in UAV technology at Singapore Airshow 2014

2014-02-10

Nanyang Technological University (NTU) will be showcasing its latest R&D expertise in Unmanned Aerial Vehicle (UAV) technology at the Singapore Airshow, one of the most important aerospace and defence exhibitions in the world, held from 11 to 16 February. Visitors to the Singapore Airshow will be able to see 12 drones, programmed by NTU scientists and researchers, flying in formation within inches of each other and executing complex indoor aerial manoeuvres. In addition to the formation air-show by 12 quad-rotor Unmanned Aerial Vehicles complete with strobe lights ...

Australians discover oldest star

2014-02-10

A team led by astronomers at The Australian National University has discovered the oldest known star in the Universe, which formed shortly after the Big Bang 13.7 billion years ago. The discovery has allowed astronomers for the first time to study the chemistry of the first stars, giving scientists a clearer idea of what the Universe was like in its infancy. "This is the first time that we've been able to unambiguously say that we've found the chemical fingerprint of a first star," said lead researcher, Dr Stefan Keller of the ANU Research School of Astronomy and Astrophysics. "This ...

New maps reveal locations of species at risk as climate changes

2014-02-10

An international team of scientists has produced global maps showing how fast and in which direction local climates have shifted. In research published today in the journal Nature, CSIRO and an international team of scientists revealed global maps showing how fast and in which direction local climates are shifting. This new study points to a simpler way of looking at climatic changes and their likely effects on biodiversity. As climate change unfolds over the next century, plants and animals will need to adapt or shift locations to track their ideal climate. "The ...

JCI early table of contents for Feb. 10, 2014

2014-02-10

Researchers identify unique regulatory T cell population in human skin Regulatory T cells (Tregs) dampen the immune response against self antigens and contribute to the prevention of autoimmunity. A skin-specific population of Tregs (mTreg) has been described in mice that has properties similar to memory T cells. In mice, some mTregs are maintained in the skin for long periods of time and suppress cutaneous autoimmunity. In this issue of the Journal of Clinical Investigation, Michael Rosenblum and colleagues at the University of California San Francisco analyzed the mTreg ...

Obesity, type 2 diabetes epidemics spreading to developing world as more own TVs, computer

2014-02-10

Lower income countries may soon be facing the same obesity and diabetes epidemics as their higher income counterparts. Ownership of televisions, cars and computers was recently found to be associated with increased rates of obesity and diabetes in lower and middle income countries, according to an international study published in CMAJ (Canadian Medical Association Journal). "Although we found no trend between household devices ownership and obesity or diabetes in high income countries, there was a stronger relation as the level of country income decreased. This relation ...

Supreme Court of Canada ruling on life support has wider impact: Hassan Rasouli

2014-02-10

In the debate over whether to withdraw life support for patients who have no hope of recovery, the recent judgment by the Supreme Court of Canada on the Hassan Rasouli case in Ontario has broader implications for health care in the country, argue authors in a commentary in CMAJ (Canadian Medical Association Journal). The Supreme Court of Canada ruled in October 2013 that physicians who recommend withdrawing life support over the wishes of substitute decision-makers must apply to Ontario's Consent and Capacity Board, "regardless of whether they feel ongoing treatment falls ...

TGen study uncovers possible genetic markers in breast cancer that spreads to the brain

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: